Development Level

Tbio 3 | 10,625
Tchem 2 | 1,890

Disease

Cancer 5 | 2,346
Obesity 5 | 616
Alzheimer's disease 4 | 644
Hypertension 4 | 287
psoriasis 4 | 6,685
Amenorrhea 3 | 60
Anorexia nervosa 3 | 59
Anxiety Disorders 3 | 37
Arthritis 3 | 248
Cocaine-Related Disorders 3 | 88
Epilepsy 3 | 346
Hypertensive disease 3 | 193
Hypoglycemia 3 | 81
Hypothyroidism 3 | 89
Irritable bowel syndrome 3 | 59
Kidney disease 3 | 396
Pain agnosia 3 | 99
Schizophrenia 3 | 501
Seizures 3 | 95
Withdrawal disorder 3 | 19
diabetes mellitus 3 | 1,663
Acromegaly 2 | 40
Adenoma 2 | 165
Alcohol dependence 2 | 107
Anovulation 2 | 20
Asthma 2 | 349
Atherosclerosis 2 | 275
Autistic Disorder 2 | 320
Bradycardia 2 | 24
Cerebrovascular disease 2 | 231
Cushing's syndrome 2 | 47
Down syndrome 2 | 548
Endometriosis 2 | 535
Fibromyalgia 2 | 22
Hyperactive behavior 2 | 31
Hyperandrogenism 2 | 32
Hyperinsulinism 2 | 63
Hypogonadism 2 | 70
Hypopituitarism 2 | 36
Infertility 2 | 163
Klinefelter's syndrome 2 | 59
Major Depressive Disorder 2 | 106
Mammary Neoplasms 2 | 410
Migraine 2 | 79
Narcolepsy 2 | 58
Osteoporosis 2 | 257
Parkinson's disease 2 | 364
Pituitary adenoma 2 | 35
Polycystic Ovary Syndrome 2 | 332
Status Epilepticus 2 | 85
Substance Withdrawal Syndrome 2 | 52
Tachycardia 2 | 17
breast carcinoma 2 | 1,614
chronic kidney disease 2 | 90
fibroadenoma 2 | 557
glioblastoma 2 | 5,572
osteosarcoma 2 | 7,933
ovarian cancer 2 | 8,484
post-traumatic stress disorder 2 | 45
Adrenal Gland Neoplasms 1 | 11
Adrenal adenoma 1 | 5
Amnestic disorder 1 | 37
Anorexia 1 | 15
Arthritis, Experimental 1 | 39
Atypical depressive disorder 1 | 6
Bulimia nervosa 1 | 15
Chronic fatigue syndrome 1 | 29
Complex regional pain syndrome 1 | 12
Eating disorder 1 | 24
Epicondylitis 1 | 19
Fatty Liver 1 | 48
Fatty liver disease 1 | 84
Fibrous dysplasia 1 | 15
Gastrointestinal system disease 1 | 50
Generalized anxiety disorder 1 | 29
Gestational Diabetes 1 | 17
Heroin dependence 1 | 30
Hyperglycemia 1 | 120
Hyperthyroidism 1 | 50
Hypogonadotropism 1 | 9
Hypotension 1 | 53
Idiopathic hypogonadotropic hypogonadism 1 | 9
Infarction, Middle Cerebral Artery 1 | 25
Insulin Resistance 1 | 48
Leiomyoma 1 | 25
Mood disorder 1 | 10
Myoma 1 | 12
Non-alcoholic Fatty Liver Disease 1 | 40
Obstructive sleep apnea 1 | 28
Ovarian hyperstimulation syndrome 1 | 15
Pain 1 | 70
Panic disorder 1 | 55
Premature ovarian failure 1 | 64
Psychomotor Disorders 1 | 7
Retinitis 1 | 9
Rhinitis 1 | 46
Stereotypic movement disorder 1 | 6
Sudden infant death syndrome 1 | 33
Uterine fibroid 1 | 29
Weight decreased 1 | 18

Tissue

Endocrine System 5 | 18,512
Female tissues 5 | 18,647
Nervous System 5 | 18,561
Cardiovascular System 4 | 17,958
Digestive Tract 4 | 18,473
Liver and Pancreas 4 | 18,136
Male tissues 4 | 17,969
Respiratory system 4 | 17,484
Skin and soft tissues 4 | 18,115
Urinary Tract 4 | 18,444
Blood and immune system 3 | 17,995

Target Family

Non-IDG 4 | 11,971
Transcription Factor 1 | 1,400

Grant Application

5R01DK054323-02 5 | 5
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Proto-oncogene c-Fos FOS Tchem Transcription Factor -4.11560 13094.7 961
Progonadoliberin-1 GNRH1 Tbio Non-IDG -3.56628 3724.8 253
Neuropeptide S NPS Tchem Non-IDG -3.89942 7090.5 86
Corticoliberin CRH Tbio Non-IDG -3.72173 5615.4 346
Leptin LEP Tbio Non-IDG -4.13745 15277.2 796